Autoantibodies neutralizing type I interferons remain a significant risk factor for critical COVID-19 pneumonia in vaccinated patients. - Antolí A; Gómez-Vázquez JL; Sierra-Fortuny A; Bermudez-Carre C; Framil M; Creus-Bachiller E; Viana-Errasti J; Rofes P; Rocamora-Blanch G; Hidalgo-Peña L; García-Serrano L; Rigo-Bonnin R; et al. (Clinical immunology (Orlando, Fla.), 2025)